Evaluation of the effect of memantine on post herpetic neuralgia (PHN)

Phase 3

• Conditions: Post Herpetic Neuralgia.; Polyneuropathy, unspecified; G61.9

• Registration Number: IRCT20180404039187N6
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Patients aged 18 to 75 years
Patients who have been suffering from painful rash for maximum 4 weeks in these patients and treated with herpes neuralgia medications

Exclusion Criteria

Patients with diabetes-induced neuropathy
Patients with cardiovascular disease
Patients with epilepsy
Patients with hepatic failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in heat and cold sensation. Timepoint: At the beginning and 8 weeks later. Method of measurement: Using a thermal probe.;Pain and numbness on the location of rash. Timepoint: At the beginning and 8 weeks later. Method of measurement: DN4 questionnaire.